Market Overview The Alzheimer's Disease Diagnostic Market is being transformed by the emergence of blood-based biomarkers that offer a less invasive, more accessible approach to diagnosis. Traditional diagnostic methods have required expensive imaging or invasive cerebrospinal fluid collection, limiting widespread adoption. Blood-based tests represent a paradigm shift, potentially...